3billion Launches Genomic Newborn Screening Service for 595 Genetic Conditions
The new 3B-NEO service uses whole exome and whole genome sequencing to identify risks for serious childhood-onset disorders before symptoms appear.
Read More
Search Results for: whole-exome sequencing
New Whole Genome and Transcriptome Assay Launches for Myeloid Malignancies
Caris Life Sciences has launched Caris ChromoSeq, a whole genome and transcriptome sequencing assay for myeloid malignancies, designed to consolidate multiple tests into a single workflow with a seven-day turnaround.
Read More
DPYD Testing Gaps Leave Colorectal Cancer Patients at Risk for Severe Drug Toxicity
Inherited variants in the DPYD gene can increase the risk of life-threatening toxicity from fluoropyrimidine-based chemotherapies, yet screening remains inconsistent across care settings.
Read More
New ctDNA Assay Aims to Detect Molecular Residual Disease Earlier in Solid Tumors
Tumor-informed blood test uses whole-exome sequencing and bioinformatics to identify trace tumor DNA before recurrence appears on imaging.
Read More
Labcorp Expands MRD Testing Portfolio for Three Cancer Types
Labcorp has expanded its MRD testing portfolio with new personalized panels for breast and lung cancer and nationwide whole-genome MRD testing for stage III colon cancer, enabling earlier detection of recurrence via ctDNA analysis.
Read More